Top news of the week: 07.12.2022.
FDA Clears First IND for a Multiplex-Base Edited Investigational Therapy
The FDA has lifted its clinical hold on Beam Therapeutics’ BEAM-201 and cleared the way for an Investigational New Drug Application, the company announced Friday.
10 Massachusetts Biopharma Companies Hiring Now
Home to many of the world's leading life science companies, the Genetown hotbed is a hub of activity. To help you in your job search, here are 10 Massachusetts biopharma companies hiring ...
FDA Outlines Path Forward for Verve’s Lead Candidate, VERVE-101
Monday, Verve Therapeutics revealed that the FDA has officially requested several buckets of additional safety information to lift the hold on its lead candidate, VERVE-101.
Janssen Bows Out as Contender for Horizon Therapeutics Buyout
Janssen (Johnson & Johnson) is no longer in the running to acquire rare disease player Horizon Therapeutics, the company announced Saturday. This leaves Amgen and Sanofi at the bidding ...
Japanese biotech firm uses tiny worms in test for pancreatic cancer
A Japanese biotech firm says it has developed the world's first early screening test for pancreatic cancer, using the powerful noses of tiny worms.
Sanofi, Amgen acknowledge Horizon interest as J&J steps back
J&J rules itself out of a bid for Horizon Therapeutics for now, Sanofi and Amgen acknowledge negotiations may or may not lead to cash offers
Bactobio raises £6M to search for new antimicrobials
U.K. biotech company Bactobio Ltd. has closed an oversubscribed £6 million ($7.4 million) bridge financing round.
Alvotech Announces Changes to its Leadership Team
Alvotech Announces Changes to its Leadership Team - read this article along with other careers information, tips and advice on BioSpace